Pharmacogenetics in reproductive and perinatal medicine-Reference-Cited by-同舟云学术

Pharmacogenetics in reproductive and perinatal medicine

Published:2010-01 Issue:1 Volume:11 Page:65-79
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Alfirevic Ana¹,Alfirevic Zarko²,Pirmohamed Munir¹

Affiliation:

1. Department of Pharmacology & Therapeutics, Sherrington Building, Ashton Street, University of Liverpool, Liverpool, Merseyside, L69 3GE, UK.

2. Liverpool Women’s Hospital, Liverpool, UK

Abstract

The clinical application of pharmacogenetics has been well accepted by some medical specialties, but not all. The aim of this review is to discuss the current use of pharmacogenetics in reproductive and perinatal medicine and to highlight areas where pharmacogenetics may be able to help in the future to predict response to medicines in terms of efficacy and safety. This applies to drugs that are specific to pregnancy and reproduction, as well as drugs prescribed for the treatment of medical disorders in pregnancy. Our review points out the need for well-designed clinical studies on the efficacy and safety of medicines used in women of childbearing age in order to define the additional utility provided by pharmacogenetic testing.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs.09.153

Reference161 articles.

1. Use of Factor V Leiden genetic testing in practice and impact on management

2. Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a Mutation

3. Clinical Pharmacology: A Discipline Called to Action for Maternal and Child Health

4. Gender in the Pharmacy: Does It Matter?

5. Amoxicillin Pharmacokinetics in Pregnant Women: Modeling and Simulations of Dosage Strategies

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fetal pharmacogenomics: A promising addition to complex neonatal care;Molecular Genetics and Metabolism;2022-09

2. Treating the placenta;Clinical Pharmacology During Pregnancy;2022

3. Associations of polymorphisms of CYP2D6 and CYP2C9 with early onset severe pre-eclampsia and response to labetalol therapy;Archives of Gynecology and Obstetrics;2018-05-22

4. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives;Pharmacogenomics;2017-04

5. Advances in the Prevention of Infection-Related Preterm Birth;Frontiers in Immunology;2015-11-16